
    
      48 Couples will be added to the protocol and a single dose applied by the male member of the
      couple. The female member of the couple will have undergone a baseline pharmacokinetic
      monitoring of her endogenous levels of Testosterone. At precise intervals by cohort on the
      day of the trial, the male will expose the skin onto which the trial materials were applied
      to the skin of his partner and she will then undergo another 24-hour multiple sample
      monitoring of her levels of testosterone.
    
  